Skip to main content
Hit enter to search or ESC to close
Close Search
touchlight logo
search
Menu
  • Applications
    • ApplicationsOur enzymatic DNA technology supports a range of genetic applications, including mRNA, AAV, gene editing, and non-viral therapies. Designed for speed, precision, and scalability, our solutions help you drive innovation in genetic medicine.
      READ MORE
    • Column 2
      • Genome-editing iconGene EditingOptimised gene editing production with enzymatic DNA technology
      • AAV iconAAVOptimised AAV production with enzymatic DNA technology
    • Column 3
      • mRNA iconmRNAOptimised mRNA production with z- dbDNA™
      • Lentivirus iconLentivirusOptimised lentivirus production with enzymatic DNA technology
    • Column 4
      • DNA-vaccines iconDNA VaccinesOptimised DNA vaccine production with enzymatic DNA technology
      • Non-viral-therapy iconNon-viral gene therapyOptimised non-viral gene therapy production with enzymatic DNA technology
  • Custom Manufacturing
    • Discovery Scale
    • R&D Scale
    • SMart Scale
    • GMP Scale
  • Catalogue Products
    • NVGT
    • Lentivirus
    • AAV
    • Gene Editing
    • mRNA Construct
  • Our Technology
    • dbDNA™
    • z- dbDNA™
    • mbDNA™ + Custom Circles
  • About us
    • About Touchlight
    • Our Team
    • Our Facilities
    • Careers
    • News
    • Events
  • Resources
  • Contact Us
  • search
Dec 02

Synthetic dbDNA™ Drives a Sustainable Future for Genetic Medicines

By Alexandria Salam Resources
As advanced therapies continue to transform the healthcare landscape, the need for sustainable manufacturing solutions grows more critical. Traditional plasmid DNA (pDNA) production presents costly, resource-intensive challenges, threatening scalability and…
Read More
May 28

Transforming the Economics of AAV Production whilst Optimising Quality Using dbDNA™

By Alexandria Salam Resources
TOM MERRITT, PH.D. Traditional methods for the production of adeno-associated viral (AAV) vectors — crucial components in gene therapies — rely on plasmid DNA (pDNA), which can pose safety concerns…
Read More
  • Previous
  • 1
  • 2

Do you need support or have questions?

Find out how our cell-free DNA technology could accelerate your genetic medicine projects.

  • Industry-leading expertise in enzymatic DNA production.
  • Custom solutions tailored to your specific research needs.
  • Scalable, high-purity DNA to support innovative therapies.
  • Let’s drive innovation in genetic medicine with enzymatic DNA technology together.
GET IN TOUCH

Get the latest Touchlight news, trends and innovative solutions in genetic medicine.

Sign up for our newsletter, Cell-Free Insights

touchlight logo

Touchlight pioneers scalable, cell-free DNA technology, transforming gene therapy and genetic medicine. With a commitment to innovation, excellence, and a diverse team, we push boundaries to deliver safer, more efficient solutions for the future.

Applications

Gene editing

mRNA

AAV

Lentivirus

DNA Vaccines

Non-viral gene therapy

Custom Manufacturing

Discovery Scale

R&D Scale

SMart GMP Scale

GMP Scale

Useful links

Catalogue Products

About Us

Our Technology

Our Facilities

Careers

Contact

Newsletter

© 2026 Touchlight   Privacy Policy / Cookie Policy / Policies & Statements / Terms of Use / Suppliers / Biosecurity Commitment

Close Menu
  • Applications
    • AAV
    • DNA Vaccines
    • Gene editing
    • Lentivirus
    • mRNA
    • Non-viral gene therapy
  • Custom Manufacturing
    • Discovery
    • Research & Development
    • GMP
    • SMart GMP
  • Catalogue Products
    • CMV / NVGT Reporters
    • AAV
    • Lentivirus
    • mRNA Construct
  • Our Technology
    • dbDNA™
    • z- dbDNA™
    • mbDNA™ + Custom Circles
  • About us
    • Our Facilities
    • Careers
    • Our Team
  • News & Events
  • Resources
  • Contact